Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending December 15, 2022.
Here are 5 highlights from Infection Control Today®'s (ICT®’s) wide-ranging coverage of the infection prevention and control world. Everything from interviews with known opinion leaders, to the news that infection preventionists and other health care professionals can use on their jobs.
Forgotten Patients: The Immunocompromised Are Being Left Behind
Immunocompromised individuals are at higher risk of contracting COVID-19. But do the current treatments protect them? If not, then what needs to be done?
APIC Gives Advice to Protect Against the Trifecta of Infectious Diseases
Association for Professionals in Infection Control and Epidemiology released a statement on how to protect against COVID-19, influenza, and RSV.
Hot Topics in Infection Prevention and Control: Week of Dec 15, 2022
Saskia v. Popescu covers the news about COVID-19 cases, Ebola, and cholera in the week before Christmas, 2022.
COVID-19: How to Reduce Spread Without Vaccines and Monoclonal Treatments
With many of the new COVID-19 vaccines not as effective against the new variants, reducing their spread without pharmaceuticals is even more critical.
Sweden’s Pandemic Experiment: A Book Review
Kevin Kavanagh, MD, reviews a book examining the results of Sweden's controversial decisions made during the early COVID-19 pandemic.
The CDC at a Crossroads: Budget Cuts, Public Health, and the Growing Threat of Infectious Diseases
March 12th 2025Budget cuts to the CDC threaten disease surveillance, outbreak response, and public health programs, increasing risks from measles, avian flu, and future pandemics while straining health care infrastructure nationwide.
Standing Up for Science: A Rally Participant’s Perspective
March 11th 2025Infection Control Today's Editorial Advisory Board member and contributing editor, Heather Stoltzfus, MPH, RN, CIC, recently joined the Stand Up for Science rally in Washington, DC. She gives a first-person perspective on the rally and the rally-goers' strong message.